This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Komers, R. Articles by Pelikanova, T. Search for Related Content PubMed PubMed Citation Articles by Komers, R. Articles by Pelikanova, T. Social Bookmarking                         What's this?

Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes

Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, radko.komers@ medicon.cz

Renata Simkova

Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Ludmila Kazdova

Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Jana Ruzickova

Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Terezie Pelikanova

Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Introduction Angiotensin-converting enzyme (ACE) inhibitors have been shown to improve endothelial function in Type 1 diabetes. However, the potential of ACE inhibitors (ACE-I) to enhance the haemodynamic effects of L-arginine (L-arg), the precursor of nitric oxide (NO), has not been evaluated. Furthermore, angiotensin receptor blockers (ARBs), another group of inhibitors of the renin-angiotensin system (RAS), have not been studied in this context.

Methods Using a randomised, crossover design, the acute effects of L-arg (200 mg/kg) on blood pressure (BP) and renal haemodynamics were determined in uncomplicated Type 1 diabetic patients before and after three weeks of treatment with the ACE-I ramipril (5 mg/day) or the ARB losartan (50 mg/day).

Results L-arg alone did not influence BP or renal haemodynamics. BP responses to L-arg were not modulated by ACE-I or ARB. In contrast to the systemic responses, L-arg induced significant renal vasodilation after treatment with ramipril (p<0.05). Unlike ramipril, losartan did not modulate renal haemodynamic responses to L-arg. L-arg administration was paralleled by increments in plasma L-citrulline levels, determined as a measure of L-arg-induced systemic NO production. These responses were not influenced by RAS inhibitors. No changes in other indicators of the systemic and renal NO production, such as plasma and urinary nitrates/nitrites, were detected in response to L-arg alone or after treatment with RAS inhibitors.

Conclusions ACE-Is have greater potential than ARBs to enhance L-arg effects in the kidney in uncomplicated Type 1 diabetes. Neither RAS inhibitor influenced the systemic effects of L-arg. The lack of changes in renal NO indicators parallelling the haemodynamic responses, suggests that the effects of ACE-I on L-arg-induced renal haemodynamic changes could be also attributable to NO-independent mechanisms.

Key Words: angiotensin-converting enzyme inhibitors • angiotensin receptor blockers • L-arginine • blood pressure • diabetes • renal haemodynamics

References

• Wiemer G., Scholkens B., Becker RH, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-63.[Abstract/Free Full Text]
• Jeserich M., Pape L., Just H., Hornig B., Drexler H. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with congestive heart failure. Am J Cardiol 1995;76:1079-82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mancini GB, Henry GC, Macaya C. et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation 1996;94:258-65.[Abstract/Free Full Text]
• Kuga T., Mohri M., Egashira K. et al. Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. J Am Coll Cardiol 1997;30:108-12.[Abstract]
• Giugliano D., Marfella R.,Acampora R., Giunta R., Coppola L., D'Onofrio F. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension. Diabetes Care 1998;21:631-6.[Abstract]
• Komers R., Komersova K., Kazdova L., Ruzickova J., Pelikanova T. Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to Larginine in humans. J Hypertens 2000;18:51-9.[Web of Science][Medline] [Order article via Infotrieve]
• Delles C., Jacobi J., John S., Fleischmann I., Schmieder RE Effects of enalapril and eprosartan on the renal vascular nitric oxide Osystem in human essential hypertension. Kidney Int 2002;61:1462-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pieper GM Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction. Hypertension 1998;31:1047-60.[Free Full Text]
• Anderson S., Komers R. Pathogenesis of diabetic glomerulopathy: the role of glomerular hemodynamic factors. In: Mogensen CE (ed.). The Kidney and Hypertension in Diabetes Mellitus. Boston: Kluwer Academic Publishers, 2000: 281-94.
• Calver A., Collier J.,Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2548-54.[Web of Science][Medline] [Order article via Infotrieve]
• O'Driscoll G., Green D., Rankin J., Stanton K., Taylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997;100:678-84.[Web of Science][Medline] [Order article via Infotrieve]
• Arcaro G., Zenere BM, Saggiani F. et al. ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care 1999;22:1536-42.[Abstract/Free Full Text]
• Mullen MJ, Clarkson P., Donald AE et al. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. J Am Coll Cardiol 1998;31:1330-5.[Abstract/Free Full Text]
• Schalkwijk CG, Smulders RA, Lambert J., Donker AJ, Stehouwer CD ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients. Eur J Clin Invest 2000;30:853-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Giugliano D., Marfella R., Verrazzo G. et al. L-arginine for testing endothelium-dependent vascular functions in health and disease. Am J Physiol 1997;273:E606-E612.[Web of Science][Medline] [Order article via Infotrieve]
• MimranA, Ribstein J., DuCailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995;26:937-41.[Abstract/Free Full Text]
• OkamuraT.,Ayajiki K.,Toda N. Neural mechanism of pressor action of nitric oxide synthase inhibitor in anesthetized monkeys. Hypertension 1996;28:341-6.[Abstract/Free Full Text]
• Komers R., Oyama TT, Chapman JG,Allison KM,Anderson S. Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats. Hypertension 2000;34:655-61.[Web of Science]
• Gallis B., Corthals GL, Goodlett DR et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002.JBiol Chem 1999;274:30101-08.[Abstract/Free Full Text]
• Chiarelli F., Cipollone F., Romano F. et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 2000;49:1258-63.[Abstract]
• O'Byrne S., Forte P., Roberts LJ et al. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 2000;49:857-62.[Abstract]
• Tilton RG, Chang K., Hasan KS et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993;42:221-32.[Abstract]
• Baylis C., Qiu C. Importance of nitric oxide in the control of renal hemodynamics. Kidney Int 1996;49:1727-31.[Web of Science][Medline] [Order article via Infotrieve]
• Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.[Abstract/Free Full Text]
• Anderson S. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat. Miner Electrolyte Metab 1998;24:406-11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tuttle KR, Puhlman ME, Cooney SK, Short RA Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes.Am JPhysiol Renal Physiol 2002;282:F103-F112.
• Hirschberg RR, Zipser RD, Slomowitz LA, Kopple JD Glucagon and prostaglandins are mediators of amino acid-induced rise in renal hemodynamics. Kidney Int 1988;33:1147-55.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 5, No. 1, 33-38 (2004)
DOI: 10.3317/jraas.2004.006


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Komers, R. Articles by Pelikanova, T. Search for Related Content PubMed PubMed Citation Articles by Komers, R. Articles by Pelikanova, T. Social Bookmarking                         What's this?